Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

         
Total article views   Abstract views HTML views PDF downloads Totals
13,460 Dovepress* 13,460 0+ 3,219 13,460
Totals 13,460 0 3,219 13,460
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar